the effectiviness of midazolam plus ketamine versus fentanyl plus propofol according to a modified Ramsay sedation score
A Comparison of the Sedation During Endoscopy in Children
Brief Summary
The primary aim of this study was to investigate the efficiency and safety of midazolam plus ketamine versus fentanyl plus propofol administered to children undergoing UGE and to determine the most appropriate sedation protocol.
Intervention / Treatment
-
Ketamine and Midazolam (DRUG)This group was injected intravenous midazolam 0.1 mg/kg (maximum 4 mg), two minutes later, ketamine 1 mg/kg was given intravenously before the start of endoscopy.
-
Propofol and Fentanyl (DRUG)This group was injected intravenous fentanyl 1 mcg/kg, and two minutes later, propofol 1 mg/kg was given intravenously before the start of endoscopy.
Condition or Disease
- Failed Moderate Sedation During Procedure
Phase
Study Design
Study type: | INTERVENTIONAL |
---|---|
Status: | Completed |
Study results: | No Results Available |
Age: | 4 Years to 17 Years |
Enrollment: | 238 (ACTUAL) |
Funded by: | Other |
Allocation: | Randomized |
MaskingSINGLE:
|
Clinical Trial Dates
Start date: | Jan 01, 2015 | |
---|---|---|
Primary Completion: | Jul 01, 2015 | ACTUAL |
Completion Date: | Sep 01, 2015 | ACTUAL |
Study First Posted: | Apr 08, 2016 | ESTIMATED |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | Apr 08, 2016 |
Sponsors / Collaborators
Lead Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Responsible Party:
N/A
The patients were given a spray of lidocaine 10% as a topical pharyngeal anaesthesia before sedation. Intravenous midazolam bolus dose 0.1 mg/kg (maximum 4 mg) was administered to Group A. Two minutes later, ketamine bolus dose 1 mg/kg was given intravenously. Patient responses to verbal and tactile stimuli were evaluated two minutes after ketamine application. Ketamine 0.5 mg/kg (maximum of 2 mg/kg) was added in two minute intervals if adequate sedation was not achieved initially. The endoscopy process was initiated by the endoscopist if there was no response. If the patients were agitated after the procedure started, a ketamine 0.5 mg/kg single dose was applied. Intravenous fentanyl bolus dose 1µg/kg was administered to Group B. Two minutes later, propofol bolus dose 1 mg/kg was given intravenously. Patient responses to verbal and tactile stimuli were evaluated two minutes after propofol application. Propofol 0.5 mg/kg was added in two minute intervals if adequate sedation was not achieved. The endoscopy process was initiated by the endoscopist if there was no response. If the patients were agitated after the procedure started, a propofol 0.5 mg/kg single dose was applied. None of the patients were given an antidote after the process during recovery.
All patients were monitored for peripheral oxygen saturation, heart rate (HR), respiratory rate, and RSS during the procedure. Oxygen (2L/min) by nasal cannula was given to all patients during the procedure. Hypoxia (peripheral oxygen saturation \<90% during 60 seconds), apnea, laryngospasm, tachycardia (defined as 30% more than the average heart rate by age), bradycardia (30% less than the average heart rate by age), increase in oral secretions (more than enough to warrant aspiration), flushing, coughing and vomiting were assessed as complications and recorded.
All patients were monitored for peripheral oxygen saturation, heart rate (HR), respiratory rate, and RSS during the procedure. Oxygen (2L/min) by nasal cannula was given to all patients during the procedure. Hypoxia (peripheral oxygen saturation \<90% during 60 seconds), apnea, laryngospasm, tachycardia (defined as 30% more than the average heart rate by age), bradycardia (30% less than the average heart rate by age), increase in oral secretions (more than enough to warrant aspiration), flushing, coughing and vomiting were assessed as complications and recorded.
Participant Groups
-
ketamine 1 mg/kg midazolam 0.1 mg/kg
-
propofol 1 mg/kg fentanyl 1 mcg/kg
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 4 |
Maximum Age: | 17 |
Age Groups: | Child |
Healthy Volunteers: | Yes |
Inclusion Criteria:
* All the patients were in ASA (American Society of Anesthesiologists) physical status I or II.
Exclusion Criteria:
* Patients with respiratory tract infections, glaucoma, psychosis, porphyria, hypertension, metabolic or neurologic diseases, increased intracranial pressure and intracranial mass, and patients known to be allergic to the drugs used were excluded from the study.
* All the patients were in ASA (American Society of Anesthesiologists) physical status I or II.
Exclusion Criteria:
* Patients with respiratory tract infections, glaucoma, psychosis, porphyria, hypertension, metabolic or neurologic diseases, increased intracranial pressure and intracranial mass, and patients known to be allergic to the drugs used were excluded from the study.
Primary Outcomes
Secondary Outcomes
-
number of patients with adverse events that are related to study drugs
-
procedure time is defined as the time between the insertion of endoscope and removal of endoscope
-
recovery time is defined as the time from completing the endoscopy to achieving Aldrete score 10 in the recovery unit Aldrete score
More Details
NCT Number: | NCT02732132 |
---|---|
Other IDs: | 2015/18 |
Study URL: | https://clinicaltrials.gov/study/NCT02732132 |
Last updated: Sep 29, 2023